COMT and Parkinson disease: Of these, 58 (61.1%) participants had been prescribed adjunctive PD medications from one of the three drug groups: Dopamine Agonists (DA), Monoamine Oxidase Inhibitors (MAOi), or Catechol-O-Methyltransferase (COMT) inhibitors.